Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?
Executive Summary
Sen. Alexander and others remain optimistic as several holds and a filibuster threat emerge.
You may also be interested in...
Potential For Califf’s Second Term As US FDA Commissioner Surprises, Excites Stakeholders
Many supporters believe Robert Califf checks all the boxes, but if nominated he would also face many familiar confirmation challenges.
Potential For Califf’s Second US FDA Commissioner Term Surprises, Excites Stakeholders
Many supporters believe Robert Califf checks all the boxes, but if nominated he would also face many familiar confirmation challenges.
Opioids: FDA Eyes Better Prescriber Education, But Academics Urge Promotion Crackdown
US agency is convening two-day workshop on federal efforts to support healthcare provider education about pain management and safe use of the drugs; two University of Washington researchers say agency needs to exercise stricter oversight of opioid marketing and promotion.